Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 30;1(1):e000082.
doi: 10.1136/bmjpo-2017-000082. eCollection 2017.

Validation of a classification system for treatment-related mortality in children with cancer

Hadeel Hassan  1   2 , Menie Rompola  1   2 , Adam Woolf Glaser  1   2 , Sally Elizabeth Kinsey  1   2 , Robert Stephen Phillips  1   3
Affiliations

Validation of a classification system for treatment-related mortality in children with cancer

Hadeel Hassan et al. BMJ Paediatr Open. .

Abstract

Background: Death not directly due to cancer has been termed 'treatment-related mortality' (TRM). Appreciating the differences between TRM and disease-related death is critical in directing strategies to improve supportive care, interventions delivered or disease progression. Recently, a global collaboration developed and validated a consensus-based classification tool and attribution system.

Objectives: To evaluate the reliability of the newly developed consensus-based definition of TRM and explore the use of the cause-of-death attribution system outside the centre it was initially validated (Toronto, Canada). In the initial study, reviewers listed multiple causes of death. In this study, reviewers identified a primary cause for simplicity.

Setting: The paediatric haematology and oncology department at Leeds Teaching Hospital in Leeds, UK.

Participants: Two consultants and two clinical research associates (CRAs).

Methods: Thirty medical records of the most recent deaths in children with cancer, 2 and 4 weeks prior to death, were anonymised and presented to the participants. Reviewers independently classified deaths as 'treatment related mortality' or 'not treatment related' according to the algorithm developed. When TRM occurred, reviewers applied the cause-of-death attribution system to identify the primary cause of death. Inter-relater reliability was assessed using the kappa statistic (k).

Main outcome: Inter-relater reliability between CRA and consultants.

Results: Reliability of the classification was deemed 'very good' between CRA and consultants (k=0.86, 95% CI 0.72 to 0.97). Ten deaths were classified as TRM, of which infection was the most frequent cause identified. Reviewers disagreed on the primary cause of death (eg, respiratory vs infection) when applying the cause-of-death attribution system in six cases and probable and possible causes in four cases. The study identified how the algorithm may not detect TRM in patients receiving non-curative therapy.

Conclusions: The classification and cause of death attribution system could be implemented in different healthcare settings. Adaptation of the classification tool in patients receiving non-curative interventions and the cause of death attribution system should be considered.

Keywords: haematology; oncology; palliative care.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Classification of TRM in children with cancer, taken from. TRM, treatment-related mortality.
Figure 2
Figure 2
Proposed classification of TRM in children receiving non-curative therapy (NCT) only. TRM, treatment-related mortality.
See this image and copyright information in PMC

References

    1. Alexander S, Pole JD, Gibson P, et al. . Classification of treatment-related mortality in children with cancer: a systematic assessment. Lancet Oncol 2015;16:e604–e610. doi:10.1016/S1470-2045(15)00197-7 - DOI - PubMed
    1. CRUK. Children’s cancers mortality in Europe and worldwide, 2014. http://www.cancerresearchuk.org/health-professional/cancer-statistics/ch... (cited 2016 September).
    1. Kremer LC, Mulder RL, Oeffinger KC, et al. . A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer 2013;60:543–9. doi:10.1002/pbc.24445 - DOI - PMC - PubMed
    1. Blanco E, Beyene J, Maloney AM, et al. . Non-relapse mortality in pediatric acute lymphoblastic leukemia: a systematic review and meta-analysis. Leuk Lymphoma 2012;53:878–85. doi:10.3109/10428194.2011.639018 - DOI - PubMed
    1. White Y, Castle VP, Haig A. Pediatric oncology in developing countries: challenges and solutions. J Pediatr 2013;162:1090–1. doi:10.1016/j.jpeds.2013.02.035 - DOI - PubMed